Active Shortage Powder, For Solution Anti-Infective

Cefotaxime Sodium Powder, fo · 4,224 days since initial FDA posting

Brand: CEFOTAXIME

FDA lists Cefotaxime Sodium Powder, fo as Active Shortage (Hikma Pharmaceuticals USA, Inc.).

Availability on file: Unavailable

Cefotaxime Sodium Powder, for Solution: Active Shortage

Unavailable Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Cefotaxime Sodium Powder, for Solution
Manufacturer
Hikma Pharmaceuticals USA, Inc.
Dosage Form
Powder, For Solution
Presentation
Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25)
Package NDC
0143-9931-25

Status & Timeline

Status
Active Shortage
Availability
Unavailable
First Reported
Feb 17, 2015
Last Updated
Mar 12, 2026
Therapeutic Category
Anti-Infective, Pediatric

Row fields from the FDA Drug Shortages database via openFDA.

Shortage Reason

Shortage duration is unknown at this time.

Nearby, Other Cefotaxime Shortage Records

Cefotaxime Sodium Powder, for Solution

SteriMax, Inc.

Powder, For Solution

Active Shortage

Cefotaxime Sodium Powder, for Solution

SteriMax, Inc.

Powder, For Solution

Active Shortage

Cefotaxime Sodium Powder, for Solution

Hikma Pharmaceuticals USA, Inc.

Powder, For Solution

Active Shortage

Cefotaxime Sodium Powder, for Solution

Hikma Pharmaceuticals USA, Inc.

Powder, For Solution

Active Shortage

Cefotaxime Sodium Powder, for Solution

Hikma Pharmaceuticals USA, Inc.

Powder, For Solution

Active Shortage

FDA reason on file: Shortage duration is unknown at this time. General shortage guidance lives on the tracker hub.

← All Drug Shortages